Abbott took "a deliberately very different development path ... for the waveform" behind its Volt PFA system, said Dr.

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.

Abbott (NYSE: ABT) announced today that it launched a next-generation delivery system for its neuromodulation business.

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

The intravascular lithotripsy market has undergone high growth trailblazed by J&J subsidiary Shockwave Medical.

This research aims to develop more precise, safe and effective methods for stimulating ... The team will use a specialized device, recently developed by Dr. Zanos’s team and imec — a research ...

Red light therapy used to be something that only celebrities experimented with, from Victoria Beckham to Kim Kardashian, but these days, there are a variety of devices on the market and the ...

Abbott is studying deep brain stimulation (DBS) as a potential treatment for depression, taking the technology in a direction that could advance other mental health therapies. Abbott received FDA ...

Gold, traditionally viewed as a safe-haven investment during times of inflation or economic volatility, has climbed over 15 per cent so far this year. Fed fund futures imply traders see a 66 per ...

Image depicting Abbott’s i-STAT TBI cartridge test that gets inserted into the company’s i-STAT Alinia testing instrument. Image credit: Abbott. Abbott has launched its portable whole blood test for ...